Responses in the expression of extracellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone

Journal of Microbiology

Volumn 49, Issue 6, 2011, Pages 956-964

  Visutthi, Monton ^a   Srimanote, Potjanee ^b   Voravuthikunchai, Supayang Piyawan ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

anti MRSA; extracellular proteins; methicillin resistant Staphylococcus aureus; rhodomyrtone; Rhodomyrtus tomentosa

Indexed keywords

BACTERIAL PROTEIN; RHODOMYRTONE; XANTHONE DERIVATIVE;

ARTICLE; CHEMISTRY; DRUG EFFECT; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BACTERIAL PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PROTEOMICS; XANTHONES;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; RHODOMYRTUS TOMENTOSA;

EID: 84555177733     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-011-1115-0     Document Type: Article

References (34)

1. Appendino, G., F. Bianchi, A. Minassi, O. Sterner, M. Ballero, and S. Gibbons. 2002. Oligomeric Acylphloroglucinols from Myrtle (Myrtus communis). J. Nat. Prod. 65, 334-338.
2. Bernardo, K., N. Pakulat, S. Fleer, A. Schnaith, O. Utermöhlen, O. Krut, S. Müller, and M. Krönke. 2004. Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob. Agents Chemother. 48, 546-555.
3. Clinical and Laboratory Standards Institute (CLSI). 2006. Methods for dilution antimicrobial susceptibility tests for bacterial that grow aerobically; Approved standards, 7th ed. Clinical and Laboratory Standards Institute Document M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
4. Crawford, S. E., S. Boyle-Vavra, and R. S. Daum. 2007. Community associated methicillin-resistant Staphylococcus aureus, p. 153-179. In D. C. Hooper, M. W. Scheld, and J. M. Hughes (eds.), Emerging infections, Vol. 7. American Society for Microbiology, Washington, D. C., USA.
5. Dachriyanus, Salni, M. V. Sargent, B. W. Skelton, I. Soediro, M. Sutisna, A. H. White, and E. Yulinah. 2002. Rhodomyrtone, an antibotic from Rhodomyrtus tomentosa. Aus. J. Chem. 55, 229-232.
6. Dubrac, S., I. G. Boneca, O. Poupel, and T. Msadek. 2007. New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J. Bacteriol. 189, 8257-8269.
7. Dubrac, S. and T. Msadek. 2004. Identification of genes controlled by the essential YycG/YycF two-component system of Staphylococcus aureus. J. Bacteriol. 186, 1175-1181.
8. Enoch, D. A., J. M. Bygott, M. L. Daly, and J. A. Karas. 2007. Daptomycin. J. Infect. 55, 205-213.
9. Fowler, V. G., H. W. Boucher Jr., G. R. Corey, E. Abrutyn, A. W. Karchmer, M. E. Rupp, D. P. Levine, and et al. 2006. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355, 653-665.
10. Gründing, A. and O. Schneewind. 2007. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 104, 8478-8483.
11. Herbert, S., P. Barry, and R. P. Novick. 2001. Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect. Immun. 69, 2996-3003.
12. Koszczol, C., K. Bernardo, M. Kronke, and O. Krut. 2006. Subinhibitory quinupristin/dalfopristin attenuates virulence of Staphylococcus aureus. J. Antimicrob. Chemother. 58, 564-574.
13. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
14. Lang, S., M. A. Livesley, P. A. Lambert, W. A. Littler, and T. S. Elliott. 2000. Identification of a novel antigen from Staphylococcus epidermidis. FEMS Immunol. Med. Microbiol. 29, 213-220.
15. Limsuwan, S., E. N. Trip, T. R. Kouwen, S. Piersma, A. Hiranrat, W. Mahabusarakam, S. P. Voravuthikunchai, J. M. van Dijl, and O. Kayser. 2009. Rhodomyrtone, a new candidate as natural antibacterial drug from Rhodomyrtus tomentosa. Phytomedicine 16, 645-651.
16. Lindqvist, M., B. Isaksson, A. Samuelsson, L. Nilsson, and A. Hallgren. 2009. A clonal outbreak of methicillin-susceptible Staphylococcus aureus with concomitant resistance to erythromycin, clindamycin and tobramycin in a Swedish county. Scand. J. Infect. Dis. 41, 324-333.
17. Lorenz, U., K. Ohlsen, H. Karch, M. Hecker, A. Thiede, and J. Hacker. 2000. Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus. FEMS. Immunol. Med. Microbiol. 29, 145-153.
18. Marco, F., C. G. de la Mària, Y. Armero, E. Amat, D. Soy, A. Moreno, A. del Río, and et al. 2008. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 52, 2538-2543.
19. Martin, P. K., Y. Bao, E. Boyer, K. M. Winterberg, L. McDowell, M. B. Schmid, and J. M. Buysse. 2002. Novel locus required for expression of high-level macrolide-lincosamide streptogramin B resistance in Staphylococcus aureus. J. Bacteriol. 184, 5810-5813.
20. Ohlsen, K., W. Ziebuhr, K. P. Koller, W. Hell, T. A. Wichelhaus, and J. Hacker. 1998. Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 42, 2817-2823.
21. Oku, Y., K. Kurokawa, M. Matsuo, S. Yamada, B. L. Lee, and K. Sekimizu. 2009. Pleiotropic roles of polyglycerolphosphate synthase of lipoteichoic acid in growth of Staphylococcus aureus cells. J. Bacteriol. 191, 141-151.
22. Rosenbluh, A., C. D. B. Banner, R. Losick, and P. C. Fitz-James. 1981. Identification of a new developmental locus in Bacillus subtilis by construction of a deletion mutation in a cloned gene under sporulation control. J. Bacteriol. 148, 341-351.
23. Saising, J., A. Hiranrat, W. Mahabusarakam, M. Ongsakul, and S. P. Voravuthikunchai. 2008. Rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. as a natural antibiotic for staphylococcal cutaneous infections. J. Health. Sci. 54, 589-595.
24. Schempp, C. M., K. Pelz, A. Wittmer, E. Schopf, and J. C. Simon. 1999. Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and Gram-positive bacteria. Lancet 353, 2129.
25. Schirner, K., J. Marles-Wright, R. J. Lewis, and J. Errington. 2009. Distinct and essential morphogenic functions for wall- and lipoteichoic acids in Bacillus subtilis. EMBO. J. 28, 830-842.
26. Schulthess, B., S. Meier, D. Homerova, C. Goerke, C. Wolz, J. Kormanec, B. Berger-Bächi, and M. Bischoff. 2009. Functional characterization of the sigmaB-dependent yabJ-spoVG operon in Staphylococcus aureus, role in methicillin and glycopeptide resistance. Antimicrob. Agents Chemother. 53, 1832-1839.
27. Sianglum, W., P. Srimanote, W. Wonglumsom, K. Kittiniyom, and S. P. Voravuthikunchai. 2011. Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate. PLoS ONE 6, e16628.
28. Sibbald, M. J., A. K. Ziebandt, S. Engelmann, M. Hecker, A. de Jong, H. J. M. Harmsen, G. C. Raangs, and et al. 2006. Mapping the pathways to staphylococcal pathogenesis by comparative secretomics. Microbiol. Mol. Biol. R. 70, 755-788.
29. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic trans fer of proteins from polyacrylamide gels to nitrocellulose sheets, procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
30. Tsiodras, S., H. S. Gold, G. Sakoulas, G. M. Eliopoulos, C. Wennersten, L. Venkataraman, R. C. Moellering, and M. J. Ferraro. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358, 207-208.
31. van der Mee-Marquet, N., C. Epinette, J. Loyau, L. Arnault, A. S. Domelier, B. Losfelt, N. Girard, R. Quentin, and the Bloodstream Infection Study Group of the Relais d'Hygiène du Centre. 2007. Staphylococcus aureus strains isolated from bloodstream infections changed significantly in 2006. J. Clin. Microbiol. 45, 851-857.
32. Vaudaux, P., P. Francois, B. Berger-Bächi, and D. P. Lew. 2001. In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus. J. Antimicrob. Chemother. 47, 163-170.
33. Ziebandt, A. K., D. Becher, K. Ohlsen, J. Hacker, M. Hecker, and S. Engelmann. 2004. The influence of agr and sigmaB in growth phase dependent regulation of virulence factors in Staphylococcus aureus. Proteomics 4, 3034-3047.
34. Ziebandt, A. K., H. Weber, J. Rudolph, R. Schmid, D. Hoper, S. Engelmann, and M. Hecker. 2001. Extracellular proteins of Staphylococcus aureus and the role of SarA and sigmaB. Proteomics 1, 480-493.